Axon Enterprise, Inc. (NASDAQ:AXON) Insider Sells $12,966,775.92 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON) insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Axon Enterprise Price Performance

Shares of AXON traded up $3.27 during trading hours on Thursday, hitting $604.56. 726,404 shares of the company were exchanged, compared to its average volume of 550,267. The firm’s fifty day moving average is $428.90 and its 200 day moving average is $353.54. The company has a market cap of $46.10 billion, a price-to-earnings ratio of 155.37, a P/E/G ratio of 14.95 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $220.77 and a fifty-two week high of $624.84.

Analysts Set New Price Targets

Several analysts have weighed in on AXON shares. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price for the company. Northland Securities upped their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Robert W. Baird upped their target price on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Massachusetts Financial Services Co. MA purchased a new stake in Axon Enterprise during the 3rd quarter valued at about $120,553,000. 1832 Asset Management L.P. purchased a new stake in Axon Enterprise during the 1st quarter valued at $81,630,000. International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter worth $871,860,000. Vanguard Group Inc. lifted its position in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Finally, Westfield Capital Management Co. LP lifted its position in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.